Overactivation of CHK1 and CHK2 can promote the survival of stressed cancer cells by allowing them to temporarily halt the cell cycle for repair, highlighting the potential for combination treatments with inhibitors of CHK1 and CHK2 [40]. Here, CHEK1 is linked to cancer.